Recipient NOD2/CARD15 Variants: A Novel Independent Risk Factor for the Development of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1, 2008, Pages 67-74

  Hildebrandt, Gerhard C ^a   Granell, Miguell ^b   Urbano Ispizua, Alvaro ^b   Wolff, Daniel ^c   Hertenstein, Bernd ^d   Greinix, Hildegard T ^e   Brenmoehl, Julia ^a   Schulz, Christian ^a   Dickinson, Anne M ^f   Hahn, Joachim ^a   Rogler, Gerhard ^a   Andreesen, Reinhard ^a   Holler, Ernst ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bronchiolitis obliterans; Chronic GVHD; NOD2; Stem cell transplantation

Indexed keywords

ALEMTUZUMAB; ARGININE; BUSULFAN; CARMUSTINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYSTEINE; FLUDARABINE; GLYCINE; LEUCINE; MELPHALAN; THYMOCYTE ANTIBODY; TRYPTOPHAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; AMINO ACID SUBSTITUTION; ARTICLE; BRONCHIOLITIS OBLITERANS; CAUCASIAN; CD34 SELECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LEUKEMIA; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; DRUG MEGADOSE; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; HYPOTHESIS; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RECIPIENT; REDUCED INTENSITY CONDITIONING; RESIDUAL VOLUME; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL DEPLETION; TOTAL LUNG CAPACITY; VITAL CAPACITY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 37349073107     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.09.009     Document Type: Article

References (49)

1. Qu N., de Haan A., Harmsen M.C., et al. Specific immune responses against airway epithelial cells in a transgenic mouse trachea transplantation model for obliterative airway disease. Transplantation 76 (2003) 1022-1028
2. Jaramillo A., Fernandez F.G., Kuo E.Y., et al. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 9 (2005) 84-93
3. Holler E., Rogler G., Herfarth H., et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 104 (2004) 889-894
4. Granell M., Urbano-Ispizua A., Arostegui J.I., et al. Effect of NOD2/CARD15 variants in T-cell-depleted allogeneic stem cell transplantation. Haematologica 91 (2006) 1372-1376
5. Hippenstiel S., Opitz B., Schmeck B., et al. Lung epithelium as a sentinel and effector system in pneumonia-molecular mechanisms of pathogen recognition and signal transduction. Respir Res 7 (2006) 97
6. Parimon T., Madtes D.K., Au D.H., et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 172 (2005) 384-390
7. Pavletic S.Z., Martin P., Lee S.J., et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institute of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant 12 (2006) 252-266
8. Hugot J.P., Zaccaria I., Cavanaugh J., et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 102 (2007) 1259-1267
9. Giachino D., van Duist M.M., Regazzoni S., et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 12 (2004) 206-212
10. van der Linde K., Boor P.P., Houwing-Duistermaat J.J., et al. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. Eur J Gastroenterol Hepatol 19 (2007) 449-459
11. Santo Tomas L.H., Loberiza Jr. F.R., Klein J.P., et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 128 (2005) 153-161
12. Holland H.K., Wingard J.R., Beschorner W.E., et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG. Blood 72 (1988) 621-627
13. Patriarca F., Skert C., Sperotto A., et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 33 (2004) 751-758
14. Palmas A., Tefferi A., Myers J.L., et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 100 (1998) 680-687
15. Dudek A.Z., Mahaseth H., DeFor T.E., et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 9 (2003) 657-666
16. Sanchez J., Torres A., Serrano J., et al. Long-term follow-up of immunosuppressive treatment for obstructive airway disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 20 (1997) 403-408
17. Chien J.W., Martin P.J., Gooley T.A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 168 (2003) 208-214
18. Beinert T., Dull T., Wolf K., et al. Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res 1 (1996) 343-348
19. Clark J.G., Schwartz D.A., Flournoy N., et al. Risk factors for air-flow obstruction in recipients of bone marrow transplants. Ann Intern Med 107 (1987) 648-656
20. Clark J.G., Crawford S.W., Madtes D.K., et al. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med 111 (1989) 368-376
21. Duncker C., Dohr D., Harsdorf S., et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single-center study of incidence, risk factors and outcome. Bone Marrow Transplant 25 (2000) 1263-1268
22. Paz H.L., Crilley P., Topolsky D.L., et al. Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning. Respiration 60 (1993) 109-114
23. Inohara N., Ogura Y., Fontalba A., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J Biol Chem 278 (2003) 5509-5512
24. Inohara N., Ogura Y., and Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 5 (2002) 76-80
25. Berrebi D., Maudinas R., Hugot J.P., et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52 (2003) 840-846
26. Hisamatsu T., Suzuki M., Reinecker H.C., et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124 (2003) 993-1000
27. Opitz B., Puschel A., Schmeck B., et al. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279 (2004) 36426-36432
28. Uehara A., Fujimoto Y., Fukase K., et al. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44 12 (2007) 3100-3111
29. Rosenstiel P., Fantini M., Brautigam K., et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124 (2003) 1001-1009
30. Ross D.J., Cole A.M., Yoshioka D., et al. Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation. Transplantation 78 (2004) 1222-1224
31. Nelsestuen G.L., Martinez M.B., Hertz M.I., et al. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 5 (2005) 1705-1713
32. Xu X., Golden J.A., Dolganov G., et al. Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens. J Heart Lung Transplant 24 (2005) 1055-1066
33. Aldhous M.C., Nimmo E.R., and Satsangi J. NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease. Gut 52 (2003) 1533-1535
34. Grimm M.C., and Pavli P. NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?. Gut 53 (2004) 1558-1560
35. Wehkamp J., Harder J., Weichenthal M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53 (2004) 1658-1664
36. Wehkamp J., Schmid M., Fellermann K., et al. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol 77 (2005) 460-465
37. Kobayashi K.S., Chamaillard M., Ogura Y., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
38. Voss E., Wehkamp J., Wehkamp K., et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281 (2006) 2005-2011
39. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol 80 (2006) 500-508
40. Dosanjh A., Wan B., Ikonen T., et al. Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD). Am J Transplant 1 (2001) 321-324
41. Farivar A.S., Mackinnon-Patterson B., McCourtie A.S., et al. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha. Exp Mol Pathol 78 (2005) 190-197
42. Naidu B., Krishnadasan B., Whyte R.I., et al. Regulatory role of IL-10 in experimental obliterative bronchiolitis in rats. Exp Mol Pathol 73 (2002) 164-170
43. Qu N., de Vos P., Schelfhorst M., et al. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas. J Heart Lung Transplant 24 (2005) 882-890
44. Burman A.C., Banovic T., Kuns R.D., et al. IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood 110 (2007) 1064-1072
45. Khalid M., Al Saghir A., Saleemi S., et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 25 (2005) 490-493
46. Chien J.W., Zhao L.P., Hansen J.A., et al. Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation. Blood 107 (2006) 2200-2207
47. Watanabe T., Kitani A., Murray P.J., et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5 (2004) 800-808
48. Kanazawa N., Okafuji I., Kambe N., et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: common genetic etiology with Blau syndrome. Blood 105 (2005) 1195-1197
49. Becker M.L., Martin T.M., Doyle T.M., et al. Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum 56 (2007) 1292-1294